Amelot Holdings, Inc. (PINKSHEETS: AMHD) announced that as part of its continuing corporate development strategy, it has engaged David E. Price, Esq. of Washington, D.C. to work alongside its current corporate attorney and Company's Secretary Andrew L. Schwab, Esq.

Mr. Price specializes in corporate law and securities matters, specifically in small to medium capitalized companies. He is the principal of Top Tier, a boutique niche of corporate attorneys, financial and equity analysts. Messrs. Price and Schwab will be working closely over the next 90 days to upgrade the Company's transparency through updating its public listing information, full submission of records to auditors and other such steps as they deem necessary to create a favorable environment for return on equity investments in the Company.

For more information on David E. Price, Esq., please go to www.TopTierStrategies.com

About Amelot Holdings, Inc. (PINKSHEETS: AMHD):

Amelot Holdings, Inc. (http://www.amelotholdings.com), a publicly traded company, is a diversified holding company that has identified Biodiesel as a multi-billion-dollar emerging Biofuel market. Amelot plans to have a significant market share in growing low cost feedstocks to supply the growing demand for biodiesel, to reduce energy dependency of fossil fuels, to help reduce the U.S. dependency on foreign oil supplies and reduce the impact of energy on our environment.

Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing and access funds from our existing financing arrangements that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events.

Contact: Amelot Holdings, Inc. 1(866)-669-8373 support@amelotholdings.com http://www.amelotholdings.com

HLK Biotech (CE) (USOTC:AMHD)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more HLK Biotech (CE) Charts.
HLK Biotech (CE) (USOTC:AMHD)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more HLK Biotech (CE) Charts.